Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis

被引:45
作者
Ding, Nan [1 ]
Liu, Xingchen [1 ]
Jian, Qihang [1 ]
Liang, Zhonghen [1 ]
Wang, Fang [1 ]
机构
[1] Lanzhou Univ, Hosp 2, Reprod Med Ctr, Lanzhou 730030, Gansu, Peoples R China
关键词
Dual trigger; Gonadotropin-releasing hormone; GnRH agonist; GnRH antagonist; Human chorionic gonadotropin; Randomized controlled trial; Meta-analysis; HUMAN CHORIONIC-GONADOTROPIN; HORMONE AGONIST; ENDOMETRIAL RECEPTIVITY; PREGNANCY RATE; LIVE-BIRTH; OVULATION; IVF;
D O I
10.1016/j.ejogrb.2017.09.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Increasing evidence indicates that a dual trigger (a gonadotrophin-releasing hormone agonist [GnRH-a] with a human chorionic gonadotrophin IhCG] trigger) is the best choice for final oocyte maturation in the GnRH antagonist (GnRH-ant) cycle. However, this conclusion remains controversial. Therefore, we performed this meta-analysis to systematically evaluate the efficacy of a GnRH-a combined with a standard hCG trigger in comparison with hCG alone for final oocyte maturation in the GnRH-ant cycle for in vitro fertilization. Study design: Complete electronic databases, including PubMed, Embase, The Cochrane Library, and Web of Science, were searched for relevant randomized controlled trials (Rcr). The search was not restricted by language or publication time. Two reviewers selected trials and assessed trial quality independently by using the Cochrane Handbook 5.1.0. Results: Four eligible RCT studies involving 527 women were included. The results of this meta-analysis indicated that the dual trigger group had a significantly higher pregnancy rate (relative risk [RR], 1.55; 95% confidence interval [CI], 1.17-2.06) than the hCG-only trigger group. No significant differences were found in the number of oocytes retrieved (weighted mean difference [WMD], 0.47; 95% CI, -0.42 to 1.37), number of mature oocytes retrieved (WMD, 0.41; 95% CI, -0.48 to 1.30), number of fertilized oocytes (WMD, 0.47; 95% CI, -0.32 to 1.26), number of good-quality embryos (WMD, 0.17; 95% CI, -0.29 to 0.64), or implantation rate (RR, 1.17; 95% CI, 0.69-2.00) between the two groups. Conclusion: GnRH-a and hCG as dual trigger was equivalent to hCG in triggering oocyte maturation and may be beneficial in improving reproductive outcomes. Further intensive randomized-controlled studies should be conducted to investigate the efficacy of the dual trigger. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 26 条
[1]   FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms [J].
Andersen, CY ;
Leonardsen, L ;
Ulloa-Aguirre, A ;
Barrios-De-Tomasi, J ;
Moore, L ;
Byskov, AG .
MOLECULAR HUMAN REPRODUCTION, 1999, 5 (08) :726-731
[2]  
Decleer W, 2014, FACTS VIEWS VIS OBGY, V6, P203
[3]   Reproductive biology and IVF: ovarian stimulation and endometrial receptivity [J].
Devroey, P ;
Bourgain, C ;
Macklon, NS ;
Fauser, BCJM .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (02) :84-90
[4]   GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study [J].
Engmann, L ;
Benadiva, C .
HUMAN REPRODUCTION, 2005, 20 (11) :3258-3260
[5]  
GONEN Y, 1990, J CLIN ENDOCR METAB, V71, P917
[6]   GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis [J].
Griesinger, G ;
Diedrich, K ;
Devroey, P ;
Kolibianakis, EM .
HUMAN REPRODUCTION UPDATE, 2006, 12 (02) :159-168
[7]   Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles [J].
Griesinger, Georg ;
Kolibianakis, E. M. ;
Papanikolaou, E. G. ;
Diedrich, K. ;
Van Steirteghem, A. ;
Devroey, P. ;
Bredkjaer, Helle Ejdrup ;
Haonaidan, Peter .
FERTILITY AND STERILITY, 2007, 88 (03) :616-621
[8]   GnRH agonist for triggering of final oocyte maturation: time for a change of practice? [J].
Humaidan, P. ;
Kol, S. ;
Papanikolaou, E. G. .
HUMAN REPRODUCTION UPDATE, 2011, 17 (04) :510-524
[9]  
Iñnarra MJ, 2015, HUM REPROD, V30, P409
[10]  
Kasum M, 2016, GYNECOL ENDOCRINOL, P1